Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C

Authors :: Bryan van den Broek
Michiel van der Flier
Nicole C.A.J. van de Kar
Jack F.M. Wetzels
Marien I. de Jonge
Ronald de Groot
Kioa L. Wijnsma
Jeroen D. Langereis
Source :: Kidney International, 101, 1293-1295, Kidney International, 101, 6, pp. 1293-1295
Publication Year :: 2022
Abstract: Item does not contain fulltext

Subjects :: Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11]
Nephrology
lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]
Humans
Renal disorders Radboud Institute for Health Sciences [Radboudumc 11]
Neisseria meningitidis, Serogroup B
Antibodies, Monoclonal, Humanized
Serogroup
Atypical Hemolytic Uremic Syndrome

ISSN :: 00852538
Database :: OpenAIRE
Journal :: Kidney International, 101, 1293-1295, Kidney International, 101, 6, pp. 1293-1295
Accession number :: edsair.doi.dedup.....b66d2c4706f610dc068bf2248b4f1a2e

Tools